BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists. 2005

Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
University Institute of Pharmaceutical Sciences, Punjab University, Chandigarh, India.

5-Nitrobenzimidazole derivatives with varying substituents at 2-position have been designed, synthesized, and evaluated for angiotensin II antagonistic activity. A drug-receptor interaction model has been proposed.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D057911 Angiotensin Receptor Antagonists Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. Angiotensin II Receptor Antagonist,Angiotensin II Receptor Blocker,Angiotensin Receptor Antagonist,Angiotensin Receptor Blocker,Angiotensin II Receptor Antagonists,Angiotensin II Receptor Blockers,Angiotensin Receptor Blockers,Antagonist, Angiotensin Receptor,Antagonists, Angiotensin Receptor,Blocker, Angiotensin Receptor,Receptor Antagonist, Angiotensin,Receptor Antagonists, Angiotensin,Receptor Blocker, Angiotensin,Receptor Blockers, Angiotensin

Related Publications

Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
September 2008, European journal of medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
March 2012, European journal of medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.
December 2008, Bioorganic & medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
January 2014, SAR and QSAR in environmental research,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists.
November 2016, European journal of medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
July 2012, Bioorganic & medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review.
December 2010, Mini reviews in medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
December 1993, Journal of medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.
August 2012, Bioorganic & medicinal chemistry,
Alka Bali, and Yogita Bansal, and M Sugumaran, and Jatinder Singh Saggu, and P Balakumar, and Gurpreet Kaur, and Gulshan Bansal, and Ajay Sharma, and Manjeet Singh
3D QSAR studies on substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist.
September 2013, Current computer-aided drug design,
Copied contents to your clipboard!